Home » BIOPURE CORP. Q2 LOSS NARROWS DESPITE LOWER REVENUES
BIOPURE CORP. Q2 LOSS NARROWS DESPITE LOWER REVENUES
Thursday morning, Biopure Corporation, a developer, manufacturer and marketer of pharmaceuticals, announced financial results for the second quarter reporting net loss that narrowed year-over-year despite lower revenues.
Trading Markets
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May